lisaftoclax,tocilizumab,rituximab
ascentage pharmaceuticals,roche
['toci', 'lisaftoclax', 'cll', 'ritux']
excellent presentation by on lisaftoclax alone and in combo with other agents in #cll - waterfall plots show nice responses, though continue to demonstrate that bcl2i monotherapy is not ideal in pts w/primarily nodal dz #ash22 
Assistant Professor of Medicine in CLL at Mayo Clinic and lifelong learner with a passion for education, hiking, and cooking. Views expressed are my own.